PREVAIL THERAPEUTICS INC's ticker is PRVL and the CUSIP is 74140Y101. A total of 96 filers reported holding PREVAIL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 4.14 and the average weighting 0.2%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 13,822,463 | $140,713,000 | 1.77% |
Omega Fund Management, LLC | 187,538 | $1,909,000 | 0.52% |
Boxer Capital, LLC | 1,123,105 | $11,433,000 | 0.40% |
RA Capital Management | 1,915,568 | $19,500,000 | 0.36% |
DAFNA Capital Management LLC | 75,000 | $764,000 | 0.25% |
QVT Financial LP | 133,690 | $1,361,000 | 0.17% |
Woodline Partners LP | 385,480 | $3,924,000 | 0.13% |
Virtus ETF Advisers LLC | 19,773 | $201,000 | 0.10% |
WEXFORD CAPITAL LP | 37,963 | $386,000 | 0.10% |
GSA CAPITAL PARTNERS LLP | 53,018 | $540,000 | 0.09% |